Vol 21, No 1 (2014)
Original articles
Published online: 2013-04-26

open access

Page views 2206
Article views/downloads 1826
Get Citation

Connect on Social Media

Connect on Social Media

Factor XIII Val34Leu polymorphism in patients with cardiac syndrome X

Gamze Babur Güler, Ulaankhuu Batgerel, Ekrem Güler, Oğuz Karaca, Çetin Geçmen, Hacı Murat Güneş, Hicaz Zencirkıran Aguş, Ali Metin Esen, Mehmet Muhsin Türkmen
DOI: 10.5603/CJ.a2013.0046
Cardiol J 2014;21(1):6-10.


Background: The aim of the study was to examine the frequency of factor XIII polymorphism among patients with cardiac syndrome X (CSX).

Methods: This study was designed as a cross-sectional and observational study. Forty-eight female patients with CSX and 36 controls matched by age, gender, diabetes, and hypertension were studied. CSX was defined as typical chest pain during rest or effort, abnormal test result for exercise ECG, and presence of angiographically normal epicardial coronary arteries after ruling out inducible spasm. Factor XIII gene polymorphism was investigated by using CVD Strip Assay (ViennaLab Diagnostic GmbH) commercial kit.

Results: The frequency of factor XIII (Val/Leu + Leu/Leu) mutation was significantly higher in patients with CSX (43%) than in controls (19%) (p = 0.02). Frequency of the Leu allele was significantly higher in the patient group (23.5% vs. 11.1%, p = 0.04). Factor XIII (Val/Leu + Leu/Leu) mutation (p = 0.01, OR = 3.42; 95% CI 1.22–9.58) and smoking (p = 0.04, OR = 3.33, 95% CI 1.05–10.58) were identified as independent predictors of the disease in multivariate regression analysis.

Conclusions: This study indicates that there is an evidence for association between factor XIII Val34Leu polymorphism and CSX.